Overview
atai Life Sciences is a publicly listed biotech platform company building a portfolio of clinical-stage mental health companies developing psychedelic and non-psychedelic treatments for depression, PTSD, anxiety, and addiction. Their subsidiaries include programs using psilocybin, DMT, MDMA, and novel compounds.
More in Psychedelics
Latest industry news
It's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
2026-06-23 · Product
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🍄 Psychedelics
Location
Berlin, Germany
Funding
Public · NASDAQ: ATAI
Website
www.atai.lifeListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →